Search results
HFA 2023: Late-Breaking Science Video Collection
Video Series
Author(s):
Harriette Van Spall
,
James L Januzzi
Added:
10 months ago
ESC-HFA 2023 – Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) joined by Dr James Januzzi (Massachusetts General Hospital, US) to discuss late-breaking science highlights of this year's ESC Heart Failure.
Trials covered in details include:
1:13: First-in-Human Study of NI006 in Patients With Amyloid Transthyretin Cardiomyopathy
1:42: TRACER-HF:Trientine-HCL for treatment of…
View more
Author(s):
Gianluigi Savarese
,
Lars H Lund
Added:
3 years ago
Heart failure (HF) is a complex clinical syndrome characterised by the reduced ability of the heart to pump and/or fill with blood.1,2 From a physiological point of view, HF can be defined as an inadequate cardiac output to meet metabolic demands or adequate cardiac output secondary to compensatory neurohormonal activation (generally manifesting as increased left ventricular filling pressure).2…
View more
Author(s):
Harriette Van Spall
,
Adriaan A Voors
Added:
2 years ago
In this in-depth conversational interview, Late-breaker host Dr Harriette Van Spall (McMaster University, CA) meets PI, Prof Adriaan Voors (University Medical Center Groningen, NL) to discuss the EMPULSE trial. The aim of the trial was to evaluate empagliflozin compared with placebo among patients with acute decompensated heart failure.
Presented first at AHA 2021, the trial showed that that…
View more
AHA 2021: Late-breaking Science Video Collection
Author(s):
Anushka Patel
,
Stephen Nicholls
,
Jeffrey Weitz
,
et al
Added:
2 years ago
Video Series
GDMT for Heart Failure
Author(s):
Edgar Francisco Carrizales-Sepúlveda
,
Alejandro Ordaz-Farías
,
José Arturo Vargas-Mendoza
,
et al
Added:
3 weeks ago
Article
Author(s):
Mattia Arrigo
,
Lars Christian Huber
,
Stephan Winnik
,
et al
Added:
3 years ago
In 1616, Sir William Harvey was the first person to describe the importance of right ventricular function.1 However, the right ventricle (RV) has received little attention in the past, with cardiology dealing mostly with the diseases of the left ventricle (LV) and their potential treatment. Since the early 1950s, however, the prognostic significance of RV function has been recognised in several…
View more
Author(s):
Artemio García-Escobar
,
Juan Manuel Grande Ingelmo
Added:
3 years ago
To the Editor,
We congratulate Nadar and Shaikh for their excellent review of the use of biomarkers in heart failure (HF), as well as the new biomarkers currently under investigation.1
Red blood cell distribution width (RDW) is a measure of the heterogeneity of distribution of red blood cell size. A high RDW implies a large variation in red blood cell (RBC) size (anisocytosis) and a low RDW…
View more
Author(s):
Giuseppe Rosano
,
Cristiana Vitale
Added:
3 years ago
Heart failure (HF) affects 1–2% of the population in developed countries and absorbs a significant amount of human and economic resources.1–3 It is a complex syndrome, characterised by a spectrum of symptoms and signs ranging from minimal loss of normal functional capacity to more severe symptoms refractory to medical therapy. It may be associated with different aetiologies and varying degrees of…
View more